Eliana E. Ochoa, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 E Ridge Rd Ste 8, Mcallen, TX 78503 Phone: 956-630-5530 Fax: 956-630-5954 |
Miguel E Morilla Holguin, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 E Savannah Ave Ste 16, Mcallen, TX 78503 Phone: 956-631-3344 Fax: 956-631-3881 |
Dr. Moeena Zain, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 E Ridge Rd, Suite # 8, Mcallen, TX 78503 Phone: 956-630-5530 Fax: 956-630-5459 |
Dr. Elsa Chang, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 E Ridge Rd, Suite # 8, Mcallen, TX 78503 Phone: 956-630-5530 Fax: 956-630-5954 |
Dr. Lia Patricia Suazo Hernandez, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 E Ridge Rd Ste 8, Mcallen, TX 78503 Phone: 956-630-5530 |
Dr. Ricardo F Garcia, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 E Ridge Rd, Suite # 8, Mcallen, TX 78503 Phone: 956-630-5530 Fax: 956-630-5954 |
News Archive
Award-winning Get With The Guidelines-Stroke hospitals are more likely than Primary Stroke Center certified hospitals to provide all the recommended guideline-based care for patients, according to new research in the Journal of the American Heart Association.
In the United States, more than 12 million children hear a minority language at home from birth. More than two-thirds hear English as well, and they reach school age with varying levels of proficiency in two languages.
This new online tool will enable consumers to search a variety of federal healthcare data sets to monitor how the health system is performing.
The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, and subsidiary of Emmaus Life Sciences, Inc., today announced that the European Commission (EC) has granted Orphan Medicinal Product designation for the company's investigational drug Levoglutamide (L-glutamine) for the treatment of sickle cell disease.
› Verified 8 days ago